Facebook Linkedin RSS Twitter Youtube
Home 2024

Therapeutics

StockWatch: Wall Street’s Leaders and Laggards of 2024
GEN Edge

StockWatch: Wall Street’s Leaders and Laggards of 2024

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma
Cancer

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

The State of Cell and Gene Therapy 2025
Artificial Intelligence

The State of Cell and Gene Therapy 2025

Starting Material Determines Cell-Based Product Quality
Bioprocessing

Starting Material Determines Cell-Based Product Quality

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics
Artificial Intelligence

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

Light-Induced Gene Therapy Disables Cancer Cells’ Mitochondria in Mice
Cancer

Light-Induced Gene Therapy Disables Cancer Cells’ Mitochondria in Mice

Signal Peptide Harnesses Exosomes for Precise Drug Delivery
Drug Discovery

Signal Peptide Harnesses Exosomes for Precise Drug Delivery

Scientists Find Clues to New Antibiotics from Phage Communities in a Single Bacterial Strain
Infectious Diseases

Scientists Find Clues to New Antibiotics from Phage Communities in a Single Bacterial Strain

Novel Link Between Cell Nutrition and Identity Could Improve Immunotherapies
News

Novel Link Between Cell Nutrition and Identity Could Improve Immunotherapies

Overcoming Cell Therapy CMC Challenges
Bioprocessing

Overcoming Cell Therapy CMC Challenges

123...807Page 1 of 807
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.